Vnitr Lek 2005, 51(4):395-396

Hyperhomocysteinemie jako rizikový faktor: fakt nebo fikce? - editorial

V. Soška
Oddělení klinického komplementu FN u sv. Anny, Brno, přednosta doc. MUDr. Vladimír Soška, CSc.

Received: May 23, 2004; Published: April 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soška V. Hyperhomocysteinemie jako rizikový faktor: fakt nebo fikce? - editorial. Vnitr Lek. 2005;51(4):395-396.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Acevedo M et al. Elevated fibrinogen and homocystein levels enhance the risk of mortality in patients from a high risk preventive cardiology clinic. Arterioscler Thromb Vasc Biol 2002; 22: 1042-1045. Go to original source... Go to PubMed...
    2. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-1610.
    3. Hackman DG et al. Emerging risk factors for the atherosclerotic vascular disease. A critical review of the evidence. JAMA 2003; 290: 932-940. Go to original source... Go to PubMed...
    4. Lange HW et al. Folate therapy increases in-stent restenosis: results from the Folate After Coronary Intervention Trial (FACIT). Presented at: American College of Cardiology 52nd Annual Scientific Meeting: Chicago, March 30, 2003.
    5. Malinow MR, Bostom AG, Kreauu RG. Homocysteine, diete and cardiovascular diseases: a statement of health care professionals from Nutrition Comittee American Heart Association. Circulation 1999; 99: 178-182. Go to original source... Go to PubMed...
    6. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
    7. Schnyder G et al. Decreased rate of coronary restenosis after lowering of plasma homocystein levels. N Engl J Med 2001; 345: 1593-1600. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.